← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

Chief Medical Officer William Grossman sold $169K of Arcus Biosciences, Inc.

Sold$168,809
$23.89Price
7,065Shares
−25%Stake

What RCUS did after the filing

Filed Jun 21Copier in Jun 22
The stock from Tue, Jun 22 open, $23.14
+27.1%
S&P 500, same days
+4.3%

Measured over 30 trading days, to the Aug 4 close.

Traded Wed, Jun 16. Filed Mon, Jun 21, 4:48 PM ET, after the close. Returns use the Jun 22 open and the Aug 4 close. Not investment advice.